EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The Cytomorphology of Melanoma with a Special Emphasis on the Immune Checkpoint Proteins CTLA-4, PD-1, and PD-L1

Markus Tiemann, Vera Samoilova, Dmitri Atiakshin, Andrey Kostin, Igor Buchwalow

Nature Cell and Science · 2023

DOI: 10.61474/ncs.2023.00013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nature Cell and Science, 2023. Verfasst von Markus Tiemann und 4 weiteren Autor:innen. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and objectives: The development of therapeutic anti-PD-1/PD-L1/CTLA-4 monoclonal antibodies, leading to the reactivation of a specific antitumor immune response, has emerged as a promising strategy for immunotherapy in various cancers, including melanoma. Given the complexity of the tumor microenvironment and the dynamic interaction between tumors and immune cells, a better understanding of the PD-1/PD-L1/CTLA-4 regulatory pathways in tumors is required.

Methods

To address this issue, we performed immunophenotyping of CTLA4/PD1/PD-L1-positive cells in melanoma via multiple immunofluorescent immunolabeling. Primary antibodies against PD-1, PD-L1, and CTLA-4, along with a panel of CD antibodies targeting various cell types (CD1a, CD3, CD8, and CD68), were utilized for immunolabelling. Tyramide signal amplification (TSA) was used to visualize bound primary anti-CTLA-4 antibodies derived from four different clones. To simultaneously detect antigens from the same host species, TSA with subsequent heat elution was performed after each immunostaining step.

Results

CTLA-4 and PD-L1 were not expressed in malignant cells in melanoma but were observed in the tumor microenvironment; especially in tumor-associated inflammatory cells such as macrophages and dendritic cells. Moreover, we found that CTLA-4 expression was not limited to T lymphocytes.

Conclusions

The detection of CTLA-4 in various cells other than T lymphocytes suggests the participation of this molecule in regulating T lymphocyte activity beyond the well-known classical scheme. The expansion of the existing ideas regarding the role of CTLA-4 may lead to the development of new approaches for improving diagnostic accuracy. Additionally, these findings suggest that CTLA-4 has more widespread effects on immune regulation.

Zitieren

APA

Tiemann, M., Samoilova, V., Atiakshin, D., Kostin, A., & Buchwalow, I. (2023). The Cytomorphology of Melanoma with a Special Emphasis on the Immune Checkpoint Proteins CTLA-4, PD-1, and PD-L1. Nature Cell and Science. https://doi.org/10.61474/ncs.2023.00013

Vancouver

Tiemann M, Samoilova V, Atiakshin D, Kostin A, Buchwalow I. The Cytomorphology of Melanoma with a Special Emphasis on the Immune Checkpoint Proteins CTLA-4, PD-1, and PD-L1. Nature Cell and Science. 2023. doi:10.61474/ncs.2023.00013

BibTeX
@article{Tiemann2023,
  author = {Tiemann, Markus and Samoilova, Vera and Atiakshin, Dmitri and Kostin, Andrey and Buchwalow, Igor},
  title = {The Cytomorphology of Melanoma with a Special Emphasis on the Immune Checkpoint Proteins CTLA-4, PD-1, and PD-L1},
  journal = {Nature Cell and Science},
  year = {2023},
  doi = {10.61474/ncs.2023.00013}
}
Kostenlos starten →